Table 2.
Summary of patient characteristics by CKD stage
| Stage 1 | Stage 2 | Stage 3 | Stages 4, 5 | |
|---|---|---|---|---|
| Males (n) | 15 | 8 | 7 | 5 |
| Age (years) | 28.1 ± 10.3 | 39.9 ± 14.1 | 46.4 ± 11.3 | 41.5 ± 16.6 |
| eGFR | 119.1 ± 21.9 | 73.4 ± 7.8 | 43.9 ± 8.9 | 16.3 ± 10.3 |
| UPCR | 0.73 ± 0.83 (0.04–2.39; 0.37) | 0.81 ± 0.85 (0.04–2.18; 0.55) | 0.86 ± 0.59 (0.20–1.97;0.71) | 4.23 ± 1.25 (2.3–5.6; 4.29) |
| Females (n) | 10 | 13 | 1 | 0 |
| Age (years) | 42.4 ± 10.6* | 43.5 ± 9.9 | 63.0 | NA |
| eGFR | 104 ± 12.8 | 74.8 ± 8.4 | 46.0 | NA |
| UPCR | 0.44 ± 0.48 (0.04–1.46; 0.24) | 1.00 ± 1.36 (0.01–3.47; 0.15) | 1.83 | NA |
Values are presented as mean ± SD and (range; median).
eGFR, estimated glomerular filtration rate (ml/min/1.73 m2); UPCR, urine protein to creatinine ratio (g/g; to convert to mg/mmol, multiply by 113.12.); NA, not applicable.
*P < 0.003; males compared to females, two-tailed t-test.